Evolution of Drug Discovery and Development

Friday, June 12, 2020, 7:00 AM - Thursday, December 31, 2020, 5:00 PM

Goal of the Program:  Presenters will provide an historical context as well as peer reviewed and up -to -date information covering various topics as detailed int he description of this activity;    improve the healthcare team's ability to explain the drug discovery and development process in the United States and implications of this process on patient care.  The focus will be to educate on the past, current, and future landscape of drug development.   We will review: before/after discovery of penicillin, effect of FDCA on drug discovery, generics, monoclonal antibodies/immunotherapy, biosimilars/interchangeability, CAR-/gene therapy, personalized medicine/biomarkers, artificial intelligence.  

1. Outline the history of early drug development and discovery
2. Describe how the drug development process has changed over time to appreciate the process in place today
3. Define the differences in approval pathways between brand and generics
4. Evaluate the place of monoclonal antibodies (mAbs) in the cancer treatment paradigm
5. Explain how the availability of biosimilars impact clinical practice
6. Outline fundamental elements of gene therapy design and development
7. Explain the impact on patient outcomes and the role of each member of the multidisciplinary team in biomarker testing
8. Recognize potential opportunities that exist for Artificial Intelligence (AI) to transform the drug development process by comparing ongoing AI initiatives in the pharmaceutical industry

This is an enduring on-line activity which opens at 7:000am on Friday, June 12, 2020 and ends on Thursday, December 31, 2020.  You must view all eight (8) modules, complete the pre-test, post-test, and final evaluation in the MyCE portion of this website to receive credit. No partial credit will be allowed. 

Once you register, please click on tab, "Online Content and Tests"  and follow the sequence.

If you are seeking continuing education Pharmacy credits, YOU MUST INCLUDE YOUR NACP#, BIRTH MONTH AND BIRTH DAY in your "Profile".  Without this vital information, you will not be credited.

Physicians and Nurses can print their certificate of completion directly from MyCE.  Please be certain your Profiles are completed correctly.

 

 

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Attendance (2.00 hours), ACPE Credits (2.00 hours), ANCC Contact Hours (2.00 hours)